SCHEMBL382490

SCHEMBL382490

CC(C)(C)c1ccccc1S(=O)(=O)[C@@](N)(CN)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
HSD11B1 P28845 2/20 0.37
MMP1 P03956 3/20 0.36
MMP13 P45452 3/20 0.36
MMP9 P14780 1/20 0.36
ALDH1A1 P00352 5/20 0.35
NPC1 O15118 1/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP2C19 P33261 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MMP2 P08253 2/20 0.34
GAA P10253 1/20 0.34
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8555311 0.87 KMT2A (0.44) SMN1; SMN2HIF1AHSD11B1ALDH1A1RAB9A
SCHEMBL8559898 0.83 SLC1A3 (0.40) SMN1; SMN2HIF1AHSD11B1ALDH1A1CYP2C19
SCHEMBL7374391 0.80 HTT (0.42) SMN1; SMN2HIF1AHSD11B1ALDH1A1
SCHEMBL382142 0.77 SMN1; SMN2 (0.44) SMN1; SMN2HIF1AHSD11B1TSHR
SCHEMBL7651608 0.77 SMN1; SMN2 (0.44) SMN1; SMN2HIF1AHSD11B1TSHR
Hydrochloric Acid SCHEMBL382912 0.76 SMN1; SMN2 (0.43) SMN1; SMN2HIF1AHSD11B1TSHR
SCHEMBL2332617 0.74 NSD2 (0.42) SMN1; SMN2HIF1ACYP1A2
SCHEMBL2327649 0.73 CA2 (0.55) HIF1ATDP1CYP2C19CYP1A2
SCHEMBL27678465 0.71 SLC1A3 (0.40) SMN1; SMN2HIF1AHSD11B1RECQLTDP1
SCHEMBL7372959 0.70 ALDH1A1 (0.45) MMP1MMP13MMP9ALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074543-B1 AMINOPIPERIDINE DERIVATIVES AS INTEGRIN ALPHA V BETA 3 ANTAGONISTS MEIJI SEIKA PHARMA CO LTD (JP) 2012-01-25 EP disclosed